DAPH 800-830: Pharmacology & Advanced Pharmacology Principles I-III

Classes

DAPH 800 : Pharmacology for the Advanced Practice Nurse: Nurse Anesthetists

This course is designed to discuss concepts related to the advanced pharmacotherapeutics of frequently encountered and prescribed non-anesthesia specific medications at the cellular and systems levels. Many patients receiving anesthesia will be concurrently receiving medications from one or more of the categories discussed. In addition to medication indications, interactions, side effects, contraindications, and important patient education; the legal requirements and implications of being a safe and conscientious provider and prescriber will be integrated throughout the course.

2.00

DAPH 810 : Advanced Pharmacology Principles I

In this course topics will include:& pharmacodynamics, pharmacokinetics, and pharmacotherapeutics of commonly used anesthesia medications and discussed at the systemic, organ, and cellular levels. Other areas addressed when applicable are the influence of genetics and integration to the clinical setting.

2.00

DAPH 820 : Advanced Pharmacology Principles II

This course is designed to build upon basic knowledge of pharmacologic mechanisms of action, cardiothoracic physiology andvasoactive medications. The course covers pathophysiologic considerations in the cardiac patient, as well as an overview ofhemodynamic goals during anesthesia. In addition, clinical pharmacology of vasoactive drugs and their application during anesthesiais included. The course assists the student to build advanced knowledge in order to use a variety of current anesthetic techniques,agents, adjunctive drugs and equipment while providing anesthesia.

2.00

DAPH 830 : Advanced Pharmacology Principles III

This course is designed to build upon DAPH 810 and 820. DAPH 830 assists the student to build advanced knowledge for safe and appropriate use of a variety of current anesthetic and pharmacologic techniques, agents, and adjuncts while providing anesthesia. Content from DAPH 810, 820 and the 2023 Drug List may be incorporated in DAPH 830.

2.00